financetom
Business
financetom
/
Business
/
AA Mission Acquisition II Insider Bought Shares Worth $3,340,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AA Mission Acquisition II Insider Bought Shares Worth $3,340,000, According to a Recent SEC Filing
Oct 7, 2025 12:57 AM

03:34 AM EDT, 10/07/2025 (MT Newswires) -- Qing Bill Sun, 10% Owner, Director, Chief Executive Officer, on October 02, 2025, executed a purchase for 334,000 shares in AA Mission Acquisition II (YCY) for $3,340,000. Following the Form 4 filing with the SEC, Sun has control over a total of 3,209,000 Class A ordinary shares of the company, with 3,209,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2075336/000121390025096740/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pyxis Oncology to Focus Resources on Lead Clinical Program PYX-201
Pyxis Oncology to Focus Resources on Lead Clinical Program PYX-201
Dec 19, 2024
05:05 PM EST, 12/19/2024 (MT Newswires) -- Pyxis Oncology ( PYXS ) said late Thursday it will focus its resources on advancing its lead clinical program, PYX-201, as part of its portfolio prioritization plan. The clinical-stage drugmaker said PYX-201 showed significant RECIST responses in head and neck squamous cell carcinoma as well as additional potential in other solid tumors. Pyxis...
Eos Energy Gets $68.3 Million Loan Advance From Department of Energy
Eos Energy Gets $68.3 Million Loan Advance From Department of Energy
Dec 19, 2024
05:10 PM EST, 12/19/2024 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) said late Thursday it received the first loan advance of $68.3 million from the Department of Energy. The amount covers both capital expenditures and operating expenses incurred as part of the company's production expansion plans tied to project Amaze in the Mon Valley Works in Pennsylvania, it...
Innovative Solutions & Support Fiscal Q4 Earnings, Sales Rise; Shares Gain After Hours
Innovative Solutions & Support Fiscal Q4 Earnings, Sales Rise; Shares Gain After Hours
Dec 19, 2024
05:09 PM EST, 12/19/2024 (MT Newswires) -- Innovative Solutions & Support (ISSC) reported fiscal Q4 earnings late Thursday of $0.18 per diluted share, up from $0.15 a year earlier. Two analysts polled by FactSet expected $0.16. Net sales in the three months ended Sept. 30 rose to $15.4 million from $13 million a year earlier. Two analysts surveyed by FactSet...
US FDA approves Ionis Pharma's genetic disorder drug
US FDA approves Ionis Pharma's genetic disorder drug
Dec 19, 2024
Dec 19 (Reuters) - The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' ( IONS ) drug to treat a rare genetic disorder, making it the company's first wholly owned drug, the health regulator's website showed on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved